Nu Skin(US:NUS) ZACKSยท2025-02-13 23:51Group 1: Earnings Performance - Nu Skin Enterprises reported quarterly earnings of $0.38 per share, exceeding the Zacks Consensus Estimate of $0.22 per share, and showing a slight increase from $0.37 per share a year ago [1] - The earnings surprise for the quarter was 72.73%, compared to a previous quarter where the company reported earnings of $0.17 per share against an expectation of $0.20, resulting in a surprise of -15% [2] - Over the last four quarters, the company has surpassed consensus EPS estimates three times [2] Group 2: Revenue Performance - The company posted revenues of $445.55 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.01%, but down from $488.64 million year-over-year [3] - Nu Skin has topped consensus revenue estimates two times over the last four quarters [3] Group 3: Stock Performance and Outlook - Nu Skin shares have declined approximately 8.3% since the beginning of the year, while the S&P 500 has gained 2.9% [4] - The current consensus EPS estimate for the upcoming quarter is $0.27 on revenues of $433.9 million, and for the current fiscal year, it is $0.76 on revenues of $1.8 billion [8] - The Zacks Industry Rank indicates that the Cosmetics industry is currently in the bottom 32% of over 250 Zacks industries, suggesting potential underperformance compared to higher-ranked industries [9] Group 4: Estimate Revisions and Ratings - Ahead of the earnings release, the estimate revisions trend for Nu Skin was unfavorable, resulting in a Zacks Rank 5 (Strong Sell) for the stock, indicating expected underperformance in the near future [7] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [6]